Gene-Metabolite Expression in Blood Can Discriminate Allergen-Induced Isolated Early from Dual Asthmatic Responses

Some asthmatic individuals undergoing allergen inhalation challenge develop an isolated early response whereas others develop a dual response (early plus late response). In the present study we have used transcriptomics (microarrays) and metabolomics (mass spectrometry) of peripheral blood to identify molecular patterns that can discriminate allergen-induced isolated early from dual asthmatic responses. Peripheral blood was obtained prior to (pre-) and 2 hours post allergen inhalation challenge from 33 study participants. In an initial cohort of 14 participants, complete blood counts indicated significant differences in neutrophil and lymphocyte counts at pre-challenge between early and dual responders. At post-challenge, significant genes (ALOX15, FADS2 and LPCAT2) and metabolites (lysolipids) were enriched in lipid metabolism pathways. Enzymes encoding for these genes are involved in membrane biogenesis and metabolism of fatty acids into pro-inflammatory and anti-inflammatory mediators. Correlation analysis indicated a strong negative correlation between ALOX15, FADS2, and IL5RA expression with 2-arachidonoylglycerophosphocholine levels in dual responders. However, measuring arachidonic acid and docosahexaenoic acid levels in a validation cohort of 19 participants indicated that the free form of DHA (nmoles/µg of protein) was significantly (p = 0.03) different between early and dual responders after allergen challenge. Collectively these results may suggest an imbalance in lipid metabolism which dictates pro- (anti-) inflammatory and pro-resolving mechanisms. Future studies with larger sample sizes may reveal novel mechanisms and therapeutic targets of the late phase asthmatic response.

[1]  K. Stefánsson,et al.  Association between IL-1beta/TNF-alpha-induced glucocorticoid-sensitive changes in multiple gene expression and altered responsiveness in airway smooth muscle. , 2001, American journal of respiratory cell and molecular biology.

[2]  L. Boulet,et al.  Decreased miR-192 expression in peripheral blood of asthmatic individuals undergoing an allergen inhalation challenge , 2012, BMC Genomics.

[3]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[4]  L. Boulet,et al.  Plasma proteomics can discriminate isolated early from dual responses in asthmatic individuals undergoing an allergen inhalation challenge , 2012, Proteomics. Clinical applications.

[5]  A. Luskin.  What the asthma end points we know and love do and do not tell us. , 2005, The Journal of allergy and clinical immunology.

[6]  H. Hotelling.  Relations Between Two Sets of Variates , 1936 .

[7]  Berthold Koletzko,et al.  Genetic variants of the FADS1 FADS2 gene cluster as related to essential fatty acid metabolism , 2010, Current opinion in lipidology.

[8]  B. Ripley,et al.  Robust Statistics , 2018, Encyclopedia of Mathematical Geosciences.

[9]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[10]  D. Cockcroft,et al.  Determination of histamine PC20. Comparison of linear and logarithmic interpolation. , 1983, Chest.

[11]  J Bousquet,et al.  Asthma. From bronchoconstriction to airways inflammation and remodeling. , 2000, American journal of respiratory and critical care medicine.

[12]  P. O'Byrne,et al.  Peripheral Blood Gene Expression Changes during Allergen Inhalation Challenge in Atopic Asthmatic Individuals , 2012, The Journal of asthma : official journal of the Association for the Care of Asthma.

[13]  B. Naylor.  The Shedding of the Mucosa of the Bronchial Tree in Asthma , 1962, Thorax.

[14]  H. Schlenk,et al.  Esterification of Fatty Acids with Diazomethane on a Small Scale , 1960 .

[15]  P. O'Byrne,et al.  Increased numbers of both airway basophils and mast cells in sputum after allergen inhalation challenge of atopic asthmatics. , 2000, American journal of respiratory and critical care medicine.

[16]  D. Ray,et al.  Regulation of cortisol bioavailability—effects on hormone measurement and action , 2012, Nature Reviews Endocrinology.

[17]  Takao Shimizu,et al.  A Single Enzyme Catalyzes Both Platelet-activating Factor Production and Membrane Biogenesis of Inflammatory Cells , 2007, Journal of Biological Chemistry.

[18]  D. Postma,et al.  Variants of the FADS1 FADS2 Gene Cluster, Blood Levels of Polyunsaturated Fatty Acids and Eczema in Children within the First 2 Years of Life , 2010, PloS one.

[19]  B. Levy.  Resolvins and protectins: natural pharmacophores for resolution biology. , 2010, Prostaglandins, leukotrienes, and essential fatty acids.

[20]  G. Gauvreau,et al.  Allergen inhalation challenge: a human model of asthma exacerbation. , 2007, Contributions to microbiology.

[21]  M. Björkholm,et al.  Eoxins are proinflammatory arachidonic acid metabolites produced via the 15-lipoxygenase-1 pathway in human eosinophils and mast cells , 2008, Proceedings of the National Academy of Sciences.

[22]  W. Busse,et al.  The immediate and late allergic response to segmental bronchopulmonary provocation in asthma. , 1997, American journal of respiratory and critical care medicine.

[23]  H. Hammad,et al.  Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma , 2008, Nature Reviews Immunology.

[24]  Hinrich W. H. Göhlmann,et al.  I/NI-calls for the exclusion of non-informative genes: a highly effective filtering tool for microarray data , 2007, Bioinform..

[25]  Jeremy J. W. Chen,et al.  Global expression profiling of theophylline response genes in macrophages: evidence of airway anti-inflammatory regulation , 2005, Respiratory research.

[26]  J. Folch,et al.  A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.

[27]  S. Gordon,et al.  EMR1, the human homolog of F4/80, is an eosinophil‐specific receptor , 2007, European journal of immunology.

[28]  I. Nelissen,et al.  Cell types involved in allergic asthma and their use in in vitro models to assess respiratory sensitization. , 2008, Toxicology in vitro : an international journal published in association with BIBRA.

[29]  L. Boulet,et al.  Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthma. , 2011, American journal of respiratory and critical care medicine.

[30]  Y. Tesfaigzi.  Regulation of mucous cell metaplasia in bronchial asthma. , 2008, Current molecular medicine.

[31]  G. Anderson,et al.  Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease , 2008, The Lancet.

[32]  P. O'Byrne,et al.  Changes in bone marrow inflammatory cell progenitors after inhaled allergen in asthmatic subjects. , 1998, American journal of respiratory and critical care medicine.

[33]  P. Howarth,et al.  The allergen specificity of the late asthmatic reaction , 2010, Allergy.

[34]  Q. Hamid,et al.  Small airway inflammation in asthma , 2001, Respiratory research.

[35]  A. Capron,et al.  High-affinity IgE receptor on eosinophils is involved in defence against parasites , 1994, Nature.

[36]  B. Levy,et al.  Resolution of inflammation in asthma. , 2012, Clinics in chest medicine.

[37]  J L Hankinson,et al.  Spirometric reference values from a sample of the general U.S. population. , 1999, American journal of respiratory and critical care medicine.

[38]  Klaus Obermayer,et al.  A new summarization method for affymetrix probe level data , 2006, Bioinform..

[39]  M. Tanemura,et al.  Hyperreactive site in the airway tree of asthmatic patients revealed by thickening of bronchial muscles. A morphometric study. , 1990, The American review of respiratory disease.

[40]  P. Barnes,et al.  Bradykinin and asthma. , 1992, Thorax.

[41]  P. O'Byrne,et al.  IL-10 production in circulating T cells differs between allergen-induced isolated early and dual asthmatic responders. , 2002, The Journal of allergy and clinical immunology.

[42]  Gordon K Smyth,et al.  Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .

[43]  G. Diette,et al.  Gene expression profiling in human asthma. , 2007, Proceedings of the American Thoracic Society.

[44]  Charles N. Serhan,et al.  Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators , 2008, Nature Reviews Immunology.

[45]  S. Wenzel.  Asthma phenotypes: the evolution from clinical to molecular approaches , 2012, Nature Medicine.

[46]  E. Bleecker,et al.  Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Cellular, mediator, and permeability changes. , 1991, The American review of respiratory disease.

[47]  C. Serhan,et al.  Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.

[48]  J. Murray,et al.  Prostaglandin D2 is released during acute allergic bronchospasm in man. , 1985, Transactions of the Association of American Physicians.

[49]  Benjamin M. Bolstad,et al.  affy - analysis of Affymetrix GeneChip data at the probe level , 2004, Bioinform..

[50]  Peter J. Huber,et al.  Robust Statistics , 2005, Wiley Series in Probability and Statistics.

[51]  F. Chilton,et al.  Regulation of arachidonate remodeling enzymes impacts eosinophil survival during allergic asthma. , 2009, American journal of respiratory cell and molecular biology.

[52]  Philippe Besse,et al.  Highlighting relationships between heterogeneous biological data through graphical displays based on regularized canonical correlation analysis , 2009 .

[53]  E. Israel,et al.  Protectin D1 Is Generated in Asthma and Dampens Airway Inflammation and Hyperresponsiveness1 , 2007, The Journal of Immunology.

[54]  R. Gentleman,et al.  Independent filtering increases detection power for high-throughput experiments , 2010, Proceedings of the National Academy of Sciences.

[55]  B. Sykes,et al.  The metabolomics of asthma: novel diagnostic potential. , 2012, Chest.

[56]  S. Wenzel,et al.  Spectrum of prostanoid release after bronchoalveolar allergen challenge in atopic asthmatics and in control groups. An alteration in the ratio of bronchoconstrictive to bronchoprotective mediators. , 1989, The American review of respiratory disease.